147 related articles for article (PubMed ID: 35460497)
1. Results from a Prospective, Open-Label, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye Disease.
Toyos M; Toyos R; Jodoin B; Bunch R
Ophthalmol Ther; 2022 Jun; 11(3):1231-1240. PubMed ID: 35460497
[TBL] [
